Sanofi And Joslin Team Up On Diabetes Discovery
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi continues to look for new, innovative ways to diversify its diabetes portfolio; its latest endeavor is a discovery collaboration with Harvard Medical School’s Joslin Diabetes Center.
You may also be interested in...
Deals of the Week: Sanofi/Joslin; Merck/Ambrx; Genentech/AC Immune; GSK/Liquidia; Roche/Seaside
Walgreens’ deal to acquire Alliance Boots vastly expands its international presence but got a chilly reception on Wall Street.
Merck Ups The Calibr Of Academic-Industry Cooperation
Merck announced March 15 that it plans to invest $90 million over the next seven years in a nonprofit biomedical research center in San Diego dubbed the California Institute for Biomedical Research, or Calibr.
Pfizer Teams With Eight Boston-Area Research Institutions In $100MM Tie-Up
The collaboration is the third in its localized Centers for Therapeutic Innovation project, intended to nudge academics toward commercial projects.